Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 83 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/9/2008 First Published: 7/1/1999


1.		Phase II/III Study of Standard and Novel Conditioning Therapy and Allogeneic Blood or Marrow Transplantation in Patients With Severe Aplastic Anemia or Hematologic Malignancy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				4 to 65				Other				RPCI-RP-9815 NCI-V99-1527, NCT00003816, RP 98-15


2.		Stem Cell Transplantation for Hematological Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				35 and under				Other				0005M52481 MT2000-12, NCT00176839


3.		Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				12 to 55				Pharmaceutical / Industry				GC P#02.01.001 NCT00469729

Last Modified: 6/9/2008 First Published: 9/26/2007


4.		Phase II/III Study of Disease-Specific High-Dose Conditioning Regimens Followed by Autologous Stem Cell Transplantation (Single or Tandem) in Patients With Hematologic Malignancies or Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				4 and over				NCI				RPCI-I-72806 I 72806, NCT00536601

Last Modified: 10/11/2008 First Published: 9/23/2006


5.		Phase III Randomized Study of Graft-Versus-Host Disease Prophylaxis Comprising Tacrolimus and Methotrexate With or Without Sirolimus in Pediatric Patients With Intermediate-Risk or High-Risk Acute Lymphoblastic Leukemia in Second Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				1 to 21 at first relapse				NCI				COG-ASCT0431 ASCT0431, COG-PBMTC-ONCO51, NCT00382109


6.		Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				66 and over				NCI, NHLBI				418 BMTCTN-0201, NCT00075816


7.		Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				2 to 21				NCI, NHLBI				467 BMT CTN 0501, 5 U01 HL69294-05, NCT00412360


8.		Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				21 and under				Other				SCT 0307 NCT00619879


9.		Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				2 to 55				NCI, NHLBI				385 BMT CTN 0402, U01 HL069294-05, NCT00406393

Last Modified: 7/10/2007 First Published: 5/1/2001


10.		Phase I/II Pilot Study of Non-Myeloablative Chemotherapy Followed By Allogeneic Stem Cell Transplantation in Pediatric Patients With Hematopoietic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				4 to 21				NCI				NCI-01-C-0125F NCT00020592

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute